143 related articles for article (PubMed ID: 38586619)
1. A Case of Type 1 Diabetes Mellitus With Endogenous Insulin Secretory Depletion Confirmed in Two Weeks.
Takizawa H; Ogawa O
Cureus; 2024 Mar; 16(3):e55616. PubMed ID: 38586619
[TBL] [Abstract][Full Text] [Related]
2. Sodium-glucose co-transporter-2 inhibitor-associated euglycemic diabetic ketoacidosis that prompted the diagnosis of fulminant type-1 diabetes: A case report.
Yasuma T; Okano Y; Tanaka S; Nishihama K; Eguchi K; Inoue C; Maki K; Uchida A; Uemura M; Suzuki T; D'Alessandro-Gabazza CN; Gabazza EC; Yano Y
World J Clin Cases; 2021 May; 9(13):3163-3169. PubMed ID: 33969104
[TBL] [Abstract][Full Text] [Related]
3. Diabetic Ketoacidosis as a Delayed Immune-Related Event after Discontinuation of Nivolumab.
Mae S; Kuriyama A; Tachibana H
J Emerg Med; 2021 Mar; 60(3):342-344. PubMed ID: 33097350
[TBL] [Abstract][Full Text] [Related]
4. A case of nivolumab-induced acute-onset type 1 diabetes mellitus in melanoma.
Sakaguchi C; Ashida K; Yano S; Ohe K; Wada N; Hasuzawa N; Matsuda Y; Sakamoto S; Sakamoto R; Uchi H; Furue M; Nomura M; Ogawa Y
Curr Oncol; 2019 Feb; 26(1):e115-e118. PubMed ID: 30853818
[TBL] [Abstract][Full Text] [Related]
5. Changes in C-Peptide Values in Children with Type 1 Diabetes - a Three-Year Study.
Novac CN; Mihai DA; Boboc AA; Platica C; Nemuc A; Radulian G
Maedica (Bucur); 2023 Jun; 18(2):182-189. PubMed ID: 37588842
[No Abstract] [Full Text] [Related]
6. Concurrent minimal change nephrotic syndrome and type 1 diabetes mellitus in an adult Japanese woman: a case report.
Nishizono R; Kogou H; Ishizaki Y; Minakawa A; Kikuchi M; Inagaki H; Sato Y; Fujimoto S
BMC Nephrol; 2020 Sep; 21(1):410. PubMed ID: 32967631
[TBL] [Abstract][Full Text] [Related]
7. Fulminant type 1 diabetes mellitus exhibits distinct clinical and autoimmunity features from classical type 1 diabetes mellitus in Chinese.
Zheng C; Zhou Z; Yang L; Lin J; Huang G; Li X; Zhou W; Wang X; Liu Z
Diabetes Metab Res Rev; 2011 Jan; 27(1):70-8. PubMed ID: 21218510
[TBL] [Abstract][Full Text] [Related]
8. Fulminant Type 1 diabetes in a pregnant woman as an initial manifestation of the insulin autoimmune syndrome.
Kim HS; Lee TY; Kim EY; Choi JH; Kim SY; Hwang YC; Kang JH; Ahn KJ; Chung HY; Jeong IK
Diabet Med; 2012 Oct; 29(10):1335-8. PubMed ID: 22356444
[TBL] [Abstract][Full Text] [Related]
9. Pembrolizumab-induced fulminant type 1 diabetes with C-peptide persistence at first referral.
Kusuki K; Suzuki S; Mizuno Y
Endocrinol Diabetes Metab Case Rep; 2020 Apr; 2020():. PubMed ID: 32478673
[TBL] [Abstract][Full Text] [Related]
10. [Clinical Analysis of 17 Adult Patients With Fulminant Type 1 Diabetes Mellitus].
Gong HP; Ren Y; Zha PP; Chen DW; Gao Y; Huang H; Wang C
Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 May; 54(3):653-658. PubMed ID: 37248600
[TBL] [Abstract][Full Text] [Related]
11. Painless Thyroiditis and Fulminant Type 1 Diabetes Mellitus in a Patient Treated with an Immune Checkpoint Inhibitor, Nivolumab.
Sakurai K; Niitsuma S; Sato R; Takahashi K; Arihara Z
Tohoku J Exp Med; 2018 Jan; 244(1):33-40. PubMed ID: 29343652
[TBL] [Abstract][Full Text] [Related]
12. A case of idiopathic type 1 diabetes with subsequent recovery of endogenous insulin secretion despite initial diagnosis of fulminant type 1 diabetes.
Kaneko K; Satake C; Yamamoto J; Takahashi H; Sawada S; Imai J; Yamada T; Katagiri H
Endocr J; 2017 Mar; 64(3):369-374. PubMed ID: 28070056
[TBL] [Abstract][Full Text] [Related]
13. Hyperglycemic hyperosmolar state in an adolescent with type 1 diabetes mellitus.
Watanabe S; Kido J; Ogata M; Nakamura K; Mizukami T
Endocrinol Diabetes Metab Case Rep; 2019 Mar; 2019():. PubMed ID: 30836328
[TBL] [Abstract][Full Text] [Related]
14. Fulminant Type 1 Diabetes Mellitus Developed about Half a Year after Discontinuation of Immune Checkpoint Inhibitor Combination Therapy with Nivolumab and Ipilimumab: A Case Report.
Yaura K; Sakurai K; Niitsuma S; Sato R; Takahashi K; Arihara Z
Tohoku J Exp Med; 2021 Aug; 254(4):253-256. PubMed ID: 34373422
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic criteria for acute-onset type 1 diabetes mellitus (2012): Report of the Committee of Japan Diabetes Society on the Research of Fulminant and Acute-onset Type 1 Diabetes Mellitus.
Kawasaki E; Maruyama T; Imagawa A; Awata T; Ikegami H; Uchigata Y; Osawa H; Kawabata Y; Kobayashi T; Shimada A; Shimizu I; Takahashi K; Nagata M; Makino H; Hanafusa T
J Diabetes Investig; 2014 Feb; 5(1):115-8. PubMed ID: 24843746
[TBL] [Abstract][Full Text] [Related]
16. A rare case of a mother with gestational diabetes complicated with fulminant type 1 diabetes mellitus post-delivery.
Ting Tai Y; Mohd Noor N
J R Coll Physicians Edinb; 2022 Jun; 52(2):120-123. PubMed ID: 36147001
[TBL] [Abstract][Full Text] [Related]
17. Non-autoimmune acute-onset type 1 diabetes mellitus newly developed in an elderly patient presenting elevation of serum pancreatic exocrine enzymes.
Kanzaki A; Matsuda M; Yokota S; Takai K; Murai J; Otsuka A; Koyama H; Nakamura T
Diabetol Int; 2022 Jan; 13(1):309-313. PubMed ID: 35059269
[TBL] [Abstract][Full Text] [Related]
18. Atezolizumab-induced fulminant type 1 diabetes mellitus occurring four months after treatment cessation.
Nishioki T; Kato M; Kataoka S; Miura K; Nagaoka T; Takahashi K
Respirol Case Rep; 2020 Dec; 8(9):e00685. PubMed ID: 33224504
[TBL] [Abstract][Full Text] [Related]
19. Clinical Characteristics of Fulminant Type 1 Diabetes Compared with Typical Type 1 Diabetes: One-Year Follow-Up Study from the Guangdong T1DM Translational Medicine Study.
Yang D; Zhou Y; Luo S; Zheng X; Ling P; Qiu L; Xu W; Liang H; Yao B; Weng J; Yan J
J Diabetes Res; 2020; 2020():8726268. PubMed ID: 32149155
[TBL] [Abstract][Full Text] [Related]
20. Report of the Committee on the classification and diagnostic criteria of diabetes mellitus.
Kuzuya T; Nakagawa S; Satoh J; Kanazawa Y; Iwamoto Y; Kobayashi M; Nanjo K; Sasaki A; Seino Y; Ito C; Shima K; Nonaka K; Kadowaki T;
Diabetes Res Clin Pract; 2002 Jan; 55(1):65-85. PubMed ID: 11755481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
